Media Advisory: "Personalized medicine -- the time is now"
Conference at SF State will explore how genomics will revolutionize medical diagnosis and treatment; prediction and prevention of disease
One-day conference focusing on the future of personalized medicine and pharmacogenomics, the application of an individual's genetic profile to improve disease diagnosis, preventative medicine and pharmaceutical treatment. Discussions and lectures will present perspectives from biotechnology, academic, diagnostic, and investment leaders. Topics include preparing students for the industry, academic research and the opportunities and challenges of personalized medicine and its potential for financial investors.
Sponsored by the San Francisco State University College of Science and Engineering Department of Biology
8 a.m. - 6 p.m. Thursday, June 5, 2008
Jack Adams Hall, Cesar Chavez Student Center, San Francisco State University, 1600 Holloway Ave., San Francisco
Scientists, educators, health professionals, biotechnology
industry personnel, investors and the general public. Speakers include Sara
Kenkare-Mitra, vice president of development sciences at Genentech; Linda
Avey and Anne Wojcicki, co-founders of 23andMe; Ken Hitchner, vice president
of Monogram Sciences; Mary Fermi, investment counselor and Dan Maher, vice
president of BioMarin Pharmaceutical, Inc.
MORE EVENT INFO:
San Francisco State University's biology department is the largest in the California State University system. SF State ranks second among all U.S. comprehensive universities whose graduates successfully enroll in Ph.D. programs. Graduates from SF State go on to successful careers at internationally recognized biotechnology companies including Genentech, Amgen, Pfizer and Merck.
-- ### --
Share this story: